Thermodynamic study of solubility for pyrazinamide in ten solvents from T = (283.15 to 323.15) K
暂无分享,去创建一个
J. Gong | Xi Fu | Shijie Xu | Keke Zhang | Peng Shi | Zhu Ming-he | Huang Shen | Huihui Zhang | Yaoyao Yang | Hui-hui Zhang
[1] S. Rohani,et al. Measurement and correlation of the solubility of rivaroxaban (form I) in binary mixtures of ethyl acetate with tetrahydrofuran, N,N-dimethylformamide, and N,N-dimethylacetamide from T = (278.15 to 318.15) K , 2016 .
[2] T. Volkova,et al. Solution thermodynamics of pyrazinamide, isoniazid, and p-aminobenzoic acid in buffers and octanol , 2015 .
[3] Shridhar H. Thorat,et al. Crystal structures of the pyrazinamide-p-aminobenzoic acid (1/1) cocrystal and the transamidation reaction product 4-(pyrazine-2-carboxamido)benzoic acid in the molten state. , 2015, Acta crystallographica. Section C, Structural chemistry.
[4] Jian-rong Wang,et al. Pharmaceutical cocrystals of the anti-tuberculosis drug pyrazinamide with dicarboxylic and tricarboxylic acids , 2015 .
[5] Min-Soo Kim,et al. Fabrication and evaluation of valsartan–polymer– surfactant composite nanoparticles by using the supercritical antisolvent process , 2014, International journal of nanomedicine.
[6] L. Brammer,et al. Coordination chemistry meets halogen bonding and hydrogen bonding: building networks from 3-iodobenzoate paddlewheel units [Cu2(3-Ibz)4(L)2] , 2013 .
[7] M. Doležal,et al. Synthesis and antimycobacterial evaluation of pyrazinamide derivatives with benzylamino substitution. , 2013, Bioorganic & medicinal chemistry letters.
[8] P. Gao,et al. Characterization of Supersaturatable Formulations for Improved Absorption of Poorly Soluble Drugs , 2012, The AAPS Journal.
[9] F. Martínez,et al. Solubility of naproxen in ethyl acetate + ethanol mixtures at several temperatures and correlation with the Jouyban–Acree model , 2012 .
[10] P. Jílek,et al. Synthesis and antimycobacterial properties of N-substituted 6-amino-5-cyanopyrazine-2-carboxamides. , 2011, Bioorganic & medicinal chemistry.
[11] M. R. Silva,et al. A New Insight into Pyrazinamide Polymorphic Forms and their Thermodynamic Relationships , 2010 .
[12] Dilip K. Kondepudi,et al. Introduction to Modern Thermodynamics , 2008 .
[13] F. Martínez,et al. Thermodynamic analysis of the solubility of naproxen in ethanol + water cosolvent mixtures , 2007 .
[14] A. Spek,et al. Long-range magnetic ordering in a TbIII-MoV cyanido-bridged quasi-one-dimensional complex. , 2007, Angewandte Chemie.
[15] K. Raghavan,et al. Grouping solvents by statistical analysis of solvent property parameters: implication to polymorph screening. , 2004, International journal of pharmaceutics.
[16] Alexander Apelblat,et al. Solubilities of l-glutamic acid, 3-nitrobenzoic acid, p-toluic acid, calcium-l-lactate, calcium gluconate, magnesium-dl-aspartate, and magnesium-l-lactate in water , 2002 .
[17] D. Grant,et al. Estimating the relative stability of polymorphs and hydrates from heats of solution and solubility data. , 2001, Journal of pharmaceutical sciences.
[18] I. Callebaut,et al. Study of the structure-activity relationships for the pyrazinamidase (PncA) from Mycobacterium tuberculosis. , 2001, The Biochemical journal.
[19] Alexander Apelblat,et al. Solubilities ofo-acetylsalicylic, 4-aminosalicylic, 3,5-dinitrosalicylic, andp-toluic acid, and magnesium-DL-aspartate in water fromT=(278 to 348) K , 1999 .
[20] M. Cain,et al. Selenium Dioxide Oxidations in the b-Carboline Area , 1980 .
[21] R. G. Hollenbeck. Determination of differential heat of solution in real solutions from variation in solubility with temperature. , 1980, Journal of pharmaceutical sciences.
[22] J. Prausnitz,et al. Estimation of Parameters for the NRTL Equation for Excess Gibbs Energies of Strongly Nonideal Liquid Mixtures , 1969 .
[23] T. Watanabé,et al. The crystal structure of a-pyrazinamide , 1960 .